Last edition
News about "Cadila Pharmaceuticals launches Bilacad Dex Syrup"
Cadila Pharmaceuticals Launches Bilacad Dex Syrup
Cadila Pharmaceuticals has announced the launch of Bilacad Dex Syrup, to address the increasing burden of respiratory and allergy-related conditions with a novel fixed-dose combination of Bilastine, Dextromethorphan, and Phenylephrine.
Cadila Pharmaceuticals Launches Bilacad Dex Syrup | 01/07/2025 | By Darshana | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members